Details for Patent: 9,511,031
✉ Email this page to a colleague
Which drugs does patent 9,511,031 protect, and when does it expire?
Patent 9,511,031 protects DORYX MPC and is included in one NDA.
Summary for Patent: 9,511,031
Title: | Controlled release doxycycline |
Abstract: | The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation. |
Inventor(s): | Lukas; Stefan (Manningham, AU), Lepore; Angelo (Rostrevor, AU), Mudge; Stuart (Northcote, AU) |
Assignee: | Mayne Pharma International Pty. Ltd. (Salisbury South, AU) |
Application Number: | 14/973,149 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,511,031 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 9,511,031
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mayne Pharma | DORYX MPC | doxycycline hyclate | TABLET, DELAYED RELEASE;ORAL | 050795-007 | May 20, 2016 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Mayne Pharma | DORYX MPC | doxycycline hyclate | TABLET, DELAYED RELEASE;ORAL | 050795-008 | May 20, 2016 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |